Mobile stroke units (MSUs) are specially equipped ambulances designed to provide rapid assessment and treatment for stroke patients at the scene. These units have advanced imaging technology, such as CT scanners, allowing for on-the-spot stroke type and severity diagnosis. With the ability to administer clot-busting medications like tissue plasminogen activator (tPA) promptly, MSUs significantly reduce treatment delays, crucial for improving outcomes in acute stroke. Additionally, they facilitate early triage, expediting transfer to appropriate stroke centres for further intervention if needed. MSUs represent a groundbreaking approach to stroke care, promising to revolutionise prehospital management and save lives.

Different Emergency Situations When MSUs are Required

Acute Ischemic Stroke - Mobile stroke units are crucial for rapid diagnosis and treatment initiation in acute ischemic strokes, ensuring prompt administration of thrombolytic therapy like tissue plasminogen activator (tPA), which significantly improves outcomes by dissolving blood clots and restoring blood flow to the brain, minimising neuronal damage and disability.
Haemorrhagic Stroke - In cases of hemorrhagic strokes, timely diagnosis through on-board imaging allows for appropriate triage and rapid transport to specialised stroke centres equipped to manage bleeding and provide neurosurgical interventions, minimising the risk of further haemorrhage and optimising outcomes for these high-risk patients.
Large Vessel Occlusion (LVO) - Mobile stroke units are essential for identifying LVO strokes quickly, enabling timely transfer to comprehensive stroke centres for endovascular thrombectomy, a highly effective treatment that involves removing the clot causing the blockage, restoring blood flow, and reducing the risk of disability and death in patients with severe strokes.
Vertebrobasilar Stroke - With the capability to perform advanced imaging, mobile stroke units are vital for diagnosing vertebrobasilar strokes promptly, ensuring rapid initiation of appropriate treatments such as anticoagulation or antiplatelet therapy, along with close monitoring to prevent recurrent strokes and mitigate the risk of complications associated with vertebrobasilar insufficiency.
Paediatric Stroke - Mobile stroke units equipped with paediatric-specific imaging capabilities are crucial for diagnosing and managing strokes in children, where early intervention is paramount to minimise long-term neurological deficits and optimise developmental outcomes, highlighting the importance of specialised stroke care tailored to the unique needs of paediatric patients.
Wake-Up Stroke- For patients experiencing wake-up strokes, mobile stroke units play a critical role in rapidly assessing eligibility for thrombolytic therapy based on imaging findings, potentially extending the treatment window and offering hope for improved outcomes by addressing ischemic damage promptly, even in cases where symptom onset is unclear.
Stroke Mimics - Mobile stroke units help differentiate true strokes from stroke mimics through advanced imaging, preventing unnecessary hospital admissions and ensuring appropriate allocation of resources while also facilitating timely diagnosis and treatment of stroke mimics, which may present with similar symptoms but require different management strategies.
Remote or Rural Areas - In remote or rural areas lacking immediate access to specialised stroke care, mobile stroke units bridge the gap by bringing advanced diagnostic capabilities and early treatment options closer to patients, improving outcomes and reducing disparities in stroke care access by overcoming geographical barriers and providing timely interventions that can be lifesaving in these underserved regions.

Conclusion

Mobile stroke units are pivotal in emergency medical care, particularly for time-sensitive conditions like stroke. Their ability to rapidly diagnose, initiate treatment, and facilitate early transfer to specialised stroke centres significantly improves outcomes, reduces disability, and saves lives. By bringing advanced diagnostic tools and interventions directly to the patient's location, mobile stroke units overcome barriers to timely access to stroke care, particularly in remote or underserved areas. As technology evolves and healthcare systems optimise their response strategies, mobile stroke units will continue to play a crucial role in revolutionising stroke care delivery and enhancing patient outcomes worldwide.

Frequently Asked Questions About Mobile Stroke Units

Q1. How do mobile stroke units differ from traditional ambulances?
A1. Mobile stroke units are equipped with specialised imaging technology, allowing for on-site stroke diagnosis, while traditional ambulances typically lack such capabilities, relying on clinical assessment alone.

Q2. What treatments can be initiated in a mobile stroke unit?
A2. Mobile stroke units can administer clot-busting medication (thrombolytics) like tissue plasminogen activator (tPA) and provide supportive care to stabilise the patient before transfer to a specialised stroke centre for further interventions.

Q3. Are mobile stroke units available in all areas?
A3. Mobile stroke units are not universally available but are being implemented in many urban areas and regions with significant stroke burdens to improve access to timely stroke care.

Q4. How does the presence of a mobile stroke unit impact patient outcomes?
A4. Studies have shown that mobile stroke units reduce treatment times, improve access to thrombolytic therapy, and result in better functional outcomes and reduced disability among stroke patients.

Q5. Can mobile stroke units treat all types of strokes?
A5. Mobile stroke units are primarily designed to diagnose and treat ischemic strokes by administering thrombolytic therapy. However, they can also identify hemorrhagic strokes and facilitate rapid transfer to specialised stroke centres for appropriate management.

References:

https://pubmed.ncbi.nlm.nih.gov/35331008/
https://www.ahajournals.org/doi/full/10.1161/STROKEAHA.121.037376